Anti-tumor activity of novel fused pyrimidine and benzodiazepine analogues
- At: 2018 FIP Congress in Glasgow (Scotland)
- Type: Poster
- By: A.SHALABY, Aya (Faculty of pharmacy, Mansoura University, Mansoura, Egypt)
Heba M. El-Hadedy1, Aya A. Shalaby* 1, Ghada S. Hassan2, Shahenda M. El-Messery2, Ahmed R. Elsheakh3
1Faculty of Pharmacy, 2Department of pharmacutical organic chemistry, Faculty of pharmacy, 3Department of pharmacology and toxocology, Faculty of pharmacy, Mansoura University, Mansoura, Egypt
- The most common cancer in women is breast cancer.
- Unfortunately, it is also the 2nd leading cause of cancer death in women.
A series of benzo[b]pyrido[4,3-e][1,4]diazepines and benzo[4,5]thiazolo[3,2-a]pyrido[4,3-d]pyrimidines has been synthesized and tested for their in vitro antitumor activity against MCF -7 breast.. The access to the whole abstract and the presentation file is available to FIP members and to congress participants of that specific congress.